Experts on lung cancer discuss treatment strategies in early non-small cell lung cancer and the role of immunotherapy.
EP. 1: Treatment Approaches for Early-Stage Lung Cancer
Patrick Forde, MBBCh offers an overview of current standard-of-care treatments as well as emerging immunotherapy options for treating early-stage, resectable non-small cell lung cancer.
EP. 2: Driving Precision Medicine Through Molecular Testing in NSCLC
Patrick Forde, MBBCh, and Tina Cascone, MD, PhD, discuss the role of molecular profiling to guide precision treatment decisions in non-small cell lung cancer, including the impact of PD-L1 status on neoadjuvant and perioperative approaches.
EP. 3: Neoadjuvant/Perioperative Immunotherapy in NSCLC
Medical professionals discuss the role of neoadjuvant/perioperative immunotherapy in subgroups of patients with NSCLC with actionable genomic aberrations, including a brief look at the ALINA and ADUARA trials.
EP. 4: Referral of Early-Stage NSCLC to Multidisciplinary Teams
Panelists examine multidisciplinary teams and coordination of care for patients with non-small cell lung cancer, including when to involve surgeons, oncologists, and radiation oncologists.
2 Commerce Drive Cranbury, NJ 08512